AAAAAA

   
Results: 1-10 |
Results: 10
MEMBRANOUS LIPODYSTROPHY CAUSED BY CHEMOT HERAPY
Authors: PINCEMAILLE B BESANCON C BALME B DEVAUX Y THOMAS L
Citation: B. Pincemaille et al., MEMBRANOUS LIPODYSTROPHY CAUSED BY CHEMOT HERAPY, Annales de dermatologie et de venereologie, 125(6-7), 1998, pp. 425-428
CONSEQUENCES OF BRAIN-DEATH ON CORONARY BLOOD-FLOW AND MYOCARDIAL-METABOLISM
Authors: HALEJCIODELOPHONT P SIAGHY EM DEVAUX Y RICHOUX JP BISCHOFF N CARTEAUX JP UNGUREANULONGROIS D BURLET C VILLEMOT JP MERTES PM
Citation: P. Halejciodelophont et al., CONSEQUENCES OF BRAIN-DEATH ON CORONARY BLOOD-FLOW AND MYOCARDIAL-METABOLISM, Transplantation proceedings, 30(6), 1998, pp. 2840-2841
PROTECTIVE EFFECTS OF LABETALOL ON MYOCARDIAL CONTRACTILE FUNCTION INBRAIN-DEAD PIGS
Authors: SIAGHY EM HALEJCIODELOPHONT P DEVAUX Y RICHOUX JP VILLEMOT JP BURLET C UNGUREANULONGROIS D MERTES PM
Citation: Em. Siaghy et al., PROTECTIVE EFFECTS OF LABETALOL ON MYOCARDIAL CONTRACTILE FUNCTION INBRAIN-DEAD PIGS, Transplantation proceedings, 30(6), 1998, pp. 2842-2843
ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS
Authors: FUMOLEAU P CHAUVIN F NAMER M BUGAT R TUBIANAHULIN M GUASTALLA JP DELOZIER T KERBRAT P DEVAUX Y FILLEUL A
Citation: P. Fumoleau et al., ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS, European journal of cancer, 33, 1997, pp. 351-351
CHEMOTHERAPY FOR SPINAL-CORD ASTROCYTOMA
Authors: BOUFFET E AMAT D DEVAUX Y DESUZINGES C
Citation: E. Bouffet et al., CHEMOTHERAPY FOR SPINAL-CORD ASTROCYTOMA, Medical and pediatric oncology, 29(6), 1997, pp. 560-562
CYCLOPHOSPHAMIDE MITOXANTRONE/MELPHALAN (CMA) REGIMEN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN METASTATIC BREAST-CANCER/
Authors: GISSELBRECHT C EXTRA JM LOTZ JP DEVAUX Y JANVIER M PENY AM GUILLEVIN L BREMOND D DELAIN M HERBRECHT R LEPAGE E MARANINCHI D
Citation: C. Gisselbrecht et al., CYCLOPHOSPHAMIDE MITOXANTRONE/MELPHALAN (CMA) REGIMEN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN METASTATIC BREAST-CANCER/, Bone marrow transplantation, 18(5), 1996, pp. 857-863
PROGNOSTIC FACTORS FOR THE SURVIVAL IN IN FILTRATING BLADDER UROTHELIAL TUMOR - RETROSPECTIVE STUDY OF 158 PATIENTS TREATED BY RADICAL CYSTECTOMY
Authors: THIEBLEMONT C FENDLER JP TRILLETLENOIR V PETRIS C CHAUVIN F BRUNATMENTIGNY M DEVAUX Y DEVONEC M GERARD JP PERRIN P
Citation: C. Thieblemont et al., PROGNOSTIC FACTORS FOR THE SURVIVAL IN IN FILTRATING BLADDER UROTHELIAL TUMOR - RETROSPECTIVE STUDY OF 158 PATIENTS TREATED BY RADICAL CYSTECTOMY, Bulletin du cancer, 83(2), 1996, pp. 139-146
PERSISTENT BACTEREMIA DUE TO BREVIBACTERIUM SPECIES IN AN IMMUNOCOMPROMISED PATIENT
Authors: LINA B CARLOTTI A LESAINT V DEVAUX Y FRENEY J FLEURETTE J
Citation: B. Lina et al., PERSISTENT BACTEREMIA DUE TO BREVIBACTERIUM SPECIES IN AN IMMUNOCOMPROMISED PATIENT, Clinical infectious diseases, 18(3), 1994, pp. 487-488
HETEROGENEITY OF NEOPLASTIC AND REACTIVE CELL-PROLIFERATION IN NON-HODGKINS-LYMPHOMAS LINKED TO PATIENT SURVIVAL
Authors: FFRENCH M MAGAUD JP FFRENCH P BERGER F DEVAUX Y DUHAUT P SHEN N COIFFIER B BRYON PA
Citation: M. Ffrench et al., HETEROGENEITY OF NEOPLASTIC AND REACTIVE CELL-PROLIFERATION IN NON-HODGKINS-LYMPHOMAS LINKED TO PATIENT SURVIVAL, American journal of clinical pathology, 101(4), 1994, pp. 413-420
PLASMA ERYTHROPOIETIN IN ESSENTIAL THROMBOCYTHEMIA
Authors: VIALA JJ VILLE D SEBBAN C ASSOULINE D DEVAUX Y HANSS M
Citation: Jj. Viala et al., PLASMA ERYTHROPOIETIN IN ESSENTIAL THROMBOCYTHEMIA, Nouvelle revue francaise d'hematologie, 35(4), 1993, pp. 423-424
Risultati: 1-10 |